Published in
Elsevier, The Lancet Oncology, 6(11), p. 543-552, 2010
DOI: 10.1016/s1470-2045(10)70090-5
Links
- ORCID
- ORCID
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Journal article published in 2010 by
Jeffrey E. Rubnitz 
,
Hiroto Inaba,
Gary Dahl,
Raul C. Ribeiro,
W. Paul Bowman,
Jeffrey Taub,
Stanley Pounds ,
Bassem I. Razzouk,
Norman J. Lacayo,
Xueyuan Cao,
Soheil Meshinchi,
Barbara Degar,
Gladstone Airewele,
Susana C. Raimondi,
Mihaela Onciu
and other authors.
,
Hiroto Inaba,
Gary Dahl,
Raul C. Ribeiro,
W. Paul Bowman,
Jeffrey Taub,
Stanley Pounds ,
Bassem I. Razzouk,
Norman J. Lacayo,
Xueyuan Cao,
Soheil Meshinchi,
Barbara Degar,
Gladstone Airewele,
Susana C. Raimondi,
Mihaela Onciu
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 